Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Histology and Histopathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9046038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients.

  1996cited by this paper
• Nuclear and cytoplasmic bcl‐2 expression in endometrial hyperplasia and adenocarcinoma

  1995cited by this paper
• Expression of bcl‐2 oncoprotein in renal cell tumours

  1995cited by this paper
• Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.

  1995cited by this paper
• Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas.

  1995cited by this paper
• Presence of the bcl‐2 protein and apoptosis in non‐hodgkin lymphomas with diffuse growth pattern

  1995cited by this paper
• Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis

  1995cited by this paper
• Demonstration of Epstein-Barr virus genomes, using polymerase chain reaction in situ hybridization in paraffin-embedded lymphoid tissues.

  1995cited by this paper
• BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation.

  1995cited by this paper
• Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1

  1995cited by this paper
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.

  1994cited by this paper
• Epstein-Barr virus persistence and virus-associated tumours.

  1994cited by this paper
• Bcl-2 protein expression and long-term survival in breast cancer.

  1994cited by this paper
• Primers frequently used for detecting the t(14;18) major breakpoint also amplify Epstein-Barr viral DNA.

  1994cited by this paper
• Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines.

  1994cited by this paper
• The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

  1994cited by this paper
• Immunohistochemical detection of bcl‐2 protein in liver lesions: bcl‐2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia

  1994cited by this paper
• Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein in vivo.

  1994cited by this paper
• Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2.

  1994cited by this paper
• bcl-2 protein in non-small-cell lung carcinoma.

  1993cited by this paper
• Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.

  1993cited by this paper
• Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

  1993cited by this paper
• Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA

  1993cited by this paper
• Expression of bcl-2 in fetal tissues suggests a role in morphogenesis.

  1993cited by this paper
• Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma

  1993cited by this paper
• Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

  1993cited by this paper
• Bcl-2 initiates a new category of oncogenes: regulators of cell death.

  1992cited by this paper
• Bcl-2: an antidote to programmed cell death.

  1992cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Epstein–Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus

  1991cited by this paper
• From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

  1991cited by this paper
• Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

  1991cited by this paper
• Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

  1990cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• The differentiated form of nasopharyngeal carcinoma contains epstein‐barr virus DNA

  1987cited by this paper
• What's new in histological classification and recognition of naso-pharyngeal carcinoma (N.P.C.).

  1986cited by this paper
• Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

  1986cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

  1985cited by this paper
• Application of epstein‐barr virus (EBV) serology to the diagnosis of north american nasopharyngeal carcinoma

  1983cited by this paper
• HLA and nasopharyngeal carcinoma in chinese —A further study

  1983cited by this paper
• Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

  1981cited by this paper

• Association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma: Experience from a North Indian tertiary care hospital.

  2024cites this paper
• Kemoradyoterapi ile Tedavi Edilen Lokal İleri Nazofarinks Karsinomlu Olgularda Bcl-2 ve CD9 Ekspresyonunun Prognostik Önemi

  2020influential citation
• A Study of Gene Expression of Survivin, its Antiapoptotic Variants, and Targeting Survivin In Vitro for Therapy in Retinoblastoma

  2016cites this paper
• Bcl-2 Immunoexpression as Radiotherapy Response Predictor in Undifferentiated Nasopharynx Carcinoma

  2015cites this paper
• Molecular Localization of Epstein-Barr Virus and BCL-2 Expression in Tissues from Patients infected with Nasopharyngeal Tumors.

  2015cites this paper
• [Lifecycles of EBV and cancer].

  2014cites this paper
• Modes of infection and oncogenesis by the Epstein–Barr virus

  2014cites this paper
• Modes of infection Epstein – Barr virus Reviews in Medical Virology

  2014cites this paper
• Targeting the sodium iodide symporter (NIS) and apoptotic genes in extrathyroidal tumors.

  2014cites this paper
• Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study

  2013cites this paper
• Epstein–Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells

  2013cites this paper
• Apoptosis-induced anti-tumor effect of Curcuma kwangsiensis polysaccharides against human nasopharyngeal carcinoma cells.

  2012cites this paper
• BCL2L12 is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma

  2011cites this paper
• Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor

  2010cites this paper
• Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells.

  2010cites this paper
• Prognostic impact of bcl‐2 expression on advanced nasopharyngeal carcinoma

  2008cites this paper
• New viewpoint to histological classification of malignant epithelial tumours of nasopharynx.

  2005cites this paper
• Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis

  2005cites this paper
• Absence of p53 Alterations in Nasopharyngeal Carcinoma Spanish Patients with Epstein–Barr Virus Infection

  2003cites this paper
• Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders.

  2003cites this paper
• Hepatocellular Carcinoma and Markers of Apoptosis (bcl-2, bax, bcl-x): Prognostic Significance

  2002cites this paper
• Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.

  2001cites this paper
• Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas.

  2001cites this paper
• Bcl-2 and LMP1 expression in nasopharyngeal carcinomas.

  2001cites this paper
• Locally advanced nasopharyngeal cancer

  2001cites this paper
• Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.

  2000cites this paper
• Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma (NPC).

  1998cites this paper
• Interactions between Epstein-Barr virus and the cell cycle control machinery.

  1998cites this paper
• Evaluation of EBV-LMPI as prognostic indicator of nasopharyngeal carcinoma in fndonesian patients

  year unknowncites this paper